This $150-million amount of money was gathered through different funding sources, including CIHR. CIHR put in over $20 million, we put in $45 million, and provincial governments put in a lot of money. Pharmaceutical companies are joining some of these projects, so there's private sector money in that $150-million pot. We have not spent one dollar of that yet. Those projects are about to start. They will be announced by both the Minister of Health and the Minister of Industry very soon.
You will see when they are announced that each one of those projects will demonstrate value in a particular disease setting where we have an opportunity to move genomics into the clinical setting, from the academic lab into the clinical setting. That program will run for four years. We hope that we will be re-funded again from the federal government so that we can rerun that program in a few years' time.